>>Peptides>>ACTH 1-13 (Adrenocorticotropic Hormone (1-13))

ACTH 1-13 (Adrenocorticotropic Hormone (1-13)) (Synonyms: Adrenocorticotropic Hormone (1-13))

Catalog No.GC31925

ACTH 1-13(Adrenocorticotropic Hormone (1-13))은 13-aa 펩타이드로, 쥐의 에탄올 유도 위 병변 모델에서 세포 보호 효과가 있습니다.

Products are for research use only. Not for human use. We do not sell to patients.

ACTH 1-13 (Adrenocorticotropic Hormone (1-13)) Chemical Structure

Cas No.: 22006-64-0

Size 가격 재고 수량
1mg
US$101.00
재고 있음
5mg
US$258.00
재고 있음
10mg
US$405.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

ACTH (1-13) is a 13-aa peptide, with cytoprotective effects in the model of ethanol induced gastric lesions in rats.

Adrenocorticotropic hormone (ACTH) is a tropic hormone produced by the anterior pituitary, regulates cortisol and androgen production and is associated with Addison disease, Cushing syndrome and Cushing disease[2].

ACTH (1-13) alone or in combination with met-enkephalin shows potent cytoprotective effects in the model of ethanol induced gastric lesions in rats, and has immunomodulatory effects[1].

[1]. Mulabegovi? N, et al. Pharmacodynamic properties of a combination of met-enkephalin and alpha 1-13 adrenocorticotropic hormone. Med Arh. 2008;62(1):41-4. [2]. Allen MJ, et al. Adrenocorticotropic Hormone (ACTH). StatPearls. 2018.7.

리뷰

Review for ACTH 1-13 (Adrenocorticotropic Hormone (1-13))

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ACTH 1-13 (Adrenocorticotropic Hormone (1-13))

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.